These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 31113432

  • 1. Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy.
    Wang W, Men Y, Wang J, Zhou Z, Chen D, Xiao Z, Feng Q, Lv J, Liang J, Bi N, Gao S, Wang L, Hui Z.
    BMC Cancer; 2019 May 22; 19(1):478. PubMed ID: 31113432
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
    Kim BH, Kim HJ, Wu HG, Kang CH, Kim YT, Lee SH, Kim DW.
    Clin Lung Cancer; 2014 Sep 22; 15(5):356-64. PubMed ID: 24996882
    [Abstract] [Full Text] [Related]

  • 4. Benefits of postoperative radiotherapy in multimodality treatment of resected small-cell lung cancer with lymph node metastasis.
    Liu WS, Zhao LJ, Wang S, Gong LL, Liu ZY, Yuan ZY, Wang P.
    Eur J Surg Oncol; 2014 Sep 22; 40(9):1156-62. PubMed ID: 24655801
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
    Feng W, Zhang Q, Fu XL, Cai XW, Zhu ZF, Yang HJ, Xiang JQ, Zhang YW, Chen HQ.
    BMC Cancer; 2015 May 02; 15():348. PubMed ID: 25934006
    [Abstract] [Full Text] [Related]

  • 7. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP, Sebastian B, Bischof M, Kugler G, Fischer JR, Schneider T.
    Thorac Cardiovasc Surg; 2016 Sep 02; 64(6):501-6. PubMed ID: 26322832
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 10. Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes.
    Billiet C, De Ruysscher D, Peeters S, Decaluwé H, Vansteenkiste J, Dooms C, Deroose CM, De Leyn P, Hendrikx M, Bulens P, Le Péchoux C, Mebis J.
    J Thorac Oncol; 2016 Sep 01; 11(9):1538-49. PubMed ID: 27374454
    [Abstract] [Full Text] [Related]

  • 11. Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.
    Hui Z, Men Y, Hu C, Kang J, Sun X, Bi N, Zhou Z, Liang J, Lv J, Feng Q, Xiao Z, Chen D, Wang Y, Li J, Wang J, Gao S, Wang L, He J.
    JAMA Oncol; 2021 Aug 01; 7(8):1178-1185. PubMed ID: 34165501
    [Abstract] [Full Text] [Related]

  • 12. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.
    Tian C, Liu G, Xu Y, Xia G, Zhang T, Huang J, Jiang H, Ming Wang J, Li B.
    Radiol Oncol; 2020 Dec 03; 55(1):66-76. PubMed ID: 33885242
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H, Nakahara R, Ishikawa Y, Suzuki H, Inoue K, Katano S, Yokoi K.
    Interact Cardiovasc Thorac Surg; 2008 Aug 03; 7(4):573-7. PubMed ID: 18413349
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improved Survival With Increased Time-To-Radiation and Sequential Chemotherapy After Surgery for pN2 Non-Small-cell Lung Cancer.
    Sura K, Grills IS, Vu CC, Stevens CW, Ye H, Guerrero TM.
    Clin Lung Cancer; 2018 Mar 03; 19(2):e185-e194. PubMed ID: 29158124
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.
    Veluswamy RR, Mhango G, Bonomi M, Neugut AI, Hershman DL, Aldridge MD, Wisnivesky JP.
    Ann Am Thorac Soc; 2013 Dec 03; 10(6):622-8. PubMed ID: 24024700
    [Abstract] [Full Text] [Related]

  • 19. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
    Li Q, Gao JM, Liang PY, Xie FY, Liu GZ.
    Ai Zheng; 2004 Nov 03; 23(11 Suppl):1463-6. PubMed ID: 15566658
    [Abstract] [Full Text] [Related]

  • 20. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
    Herskovic A, Mauer E, Christos P, Nagar H.
    J Thorac Oncol; 2017 Feb 03; 12(2):302-313. PubMed ID: 27746190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.